MX2012003183A - Proceso para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil -6-(2-piridinil) -4h-imidazo [1, 2-a] [1, 4] benzodiacepina-4-il] -propionico o la sal de sulfonato de benceno del mismo, y compuestos utiles en ese proceso. - Google Patents

Proceso para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil -6-(2-piridinil) -4h-imidazo [1, 2-a] [1, 4] benzodiacepina-4-il] -propionico o la sal de sulfonato de benceno del mismo, y compuestos utiles en ese proceso.

Info

Publication number
MX2012003183A
MX2012003183A MX2012003183A MX2012003183A MX2012003183A MX 2012003183 A MX2012003183 A MX 2012003183A MX 2012003183 A MX2012003183 A MX 2012003183A MX 2012003183 A MX2012003183 A MX 2012003183A MX 2012003183 A MX2012003183 A MX 2012003183A
Authority
MX
Mexico
Prior art keywords
bromo
propionic acid
benzodiazepine
pyridinyl
methyl ester
Prior art date
Application number
MX2012003183A
Other languages
English (en)
Other versions
MX337683B (es
Inventor
Stuart Gary Tilbrook
Andreas Schumacher
Rene Emmenegger
Original Assignee
Paion Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paion Uk Ltd filed Critical Paion Uk Ltd
Publication of MX2012003183A publication Critical patent/MX2012003183A/es
Publication of MX337683B publication Critical patent/MX337683B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)

Abstract

La invención se refiere a un nuevo proceso para preparar metil éster de ácido 3-[(4S)-8-bromo-1-metil-6-(2-piridinil)4H-imidazo[, 2-a] [1,4]benzodiacepina-4-il]-porpiónico o sulfonato de benceno de metil éster de ácido 3-[(4S)-8-bromo-1-metil-6-(2-iridinil)-4H- imidazo [1,2-a] [1,4]benzodiacepina-4-il]-propiónico (P), que comprende hacer reaccionar metil éster de ácido 3-[(S)-7-bromo-2-((R y/o S)-2-hidroxi-propilamino)-5-piridin-2-il- 3H-benzo[e] [1,4]diacepin-3-il]-propiónico de la fórmula (EM) con un agente oxidante y opcionalmente tratar el producto de la reacción bajo condiciones ácidas, de manera que se produzca el compuesto de fórmula (F) o el compuesto (P), y nuevos compuestos útiles como materiales de inicio o como intermedios para realizar el proceso.
MX2012003183A 2009-09-18 2010-09-15 Proceso para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil -6-(2-piridinil) -4h-imidazo [1, 2-a] [1, 4] benzodiacepina-4-il] -propionico o la sal de sulfonato de benceno del mismo, y compuestos utiles en ese proceso. MX337683B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09011914A EP2305647A1 (en) 2009-09-18 2009-09-18 Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
PCT/EP2010/005668 WO2011032692A1 (en) 2009-09-18 2010-09-15 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazol[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process

Publications (2)

Publication Number Publication Date
MX2012003183A true MX2012003183A (es) 2012-05-08
MX337683B MX337683B (es) 2016-03-15

Family

ID=41467237

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015018057A MX341093B (es) 2009-09-18 2010-09-15 Compuestos utiles para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(2-piridinil)-4h-imidazo[1, 2-a] [1, 4] benzodiacepina-4-il]-propionico o la sal de sulfonato de benceno del mismo.
MX2012003183A MX337683B (es) 2009-09-18 2010-09-15 Proceso para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil -6-(2-piridinil) -4h-imidazo [1, 2-a] [1, 4] benzodiacepina-4-il] -propionico o la sal de sulfonato de benceno del mismo, y compuestos utiles en ese proceso.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015018057A MX341093B (es) 2009-09-18 2010-09-15 Compuestos utiles para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(2-piridinil)-4h-imidazo[1, 2-a] [1, 4] benzodiacepina-4-il]-propionico o la sal de sulfonato de benceno del mismo.

Country Status (18)

Country Link
US (3) US9156842B2 (es)
EP (2) EP2305647A1 (es)
JP (1) JP5801309B2 (es)
KR (1) KR101801735B1 (es)
CN (1) CN102753525B (es)
AU (1) AU2010294873B2 (es)
BR (1) BR112012006053B1 (es)
CA (1) CA2774018C (es)
DK (1) DK2477967T3 (es)
ES (1) ES2555233T3 (es)
HK (1) HK1173437A1 (es)
HR (1) HRP20151316T1 (es)
HU (1) HUE028298T2 (es)
MX (2) MX341093B (es)
PL (1) PL2477967T3 (es)
PT (1) PT2477967E (es)
RU (1) RU2551848C2 (es)
WO (1) WO2011032692A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103288834B (zh) 2006-07-10 2015-07-15 Paion英国有限公司 短效苯并二氮杂*盐及其多晶型
EP2305647A1 (en) 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
CN102964349A (zh) * 2011-08-31 2013-03-13 江苏恒瑞医药股份有限公司 苯并二氮杂*衍生物的托西酸盐及其多晶型、它们的制备方法和用途
JP6199869B2 (ja) 2012-08-31 2017-09-20 パイオン ユーケー リミティド 催眠鎮静剤の投与方式
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
CN103232454A (zh) * 2013-05-05 2013-08-07 王元青 治疗精神疾病的药物
CN103230595B (zh) * 2013-05-05 2014-10-08 李友香 治疗精神疾病的组合物
CN105726495B (zh) * 2014-12-12 2019-03-29 宜昌人福药业有限责任公司 一种注射用短效苯并二氮杂卓盐药物组合物及其制备方法
CN106892924B (zh) * 2015-12-17 2021-01-08 四川科伦博泰生物医药股份有限公司 短效苯并二氮*衍生物、其制备方法及其用途
CN110511224A (zh) * 2016-04-08 2019-11-29 四川科伦药物研究院有限公司 苯并二氮杂*衍生物的盐及其晶体形式、制备方法和用途
WO2017178663A1 (en) * 2016-04-14 2017-10-19 Paion Uk Limited Orally inhaled and nasal benzodiazepines
CN108264499B (zh) * 2017-01-04 2020-10-20 江苏恒瑞医药股份有限公司 一种苯并二氮杂*衍生物的制备方法
EP3580219B1 (en) 2017-02-09 2022-04-13 Assia Chemical Industries Ltd. Process for the preparation of remimazolam and solid state forms of remimazolam salts
ES2697918A1 (es) * 2017-07-28 2019-01-29 Moehs Iberica Sl Procedimiento para preparar ester metilico del acido 3-[(3s)-7-bromo-2-oxo-5-(piridin-2-il)-2,3-dihidro-1h-[1,4]-benzodiazepin-3-il] propionico, y compuestos utiles en ese procedimiento
ES2709298B2 (es) 2017-10-13 2019-08-21 Moehs Iberica Sl Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento
CN108033964B (zh) * 2017-12-28 2021-02-09 杭州奥默医药股份有限公司 一种吡啶基咪唑并苯并二氮杂卓丙酸酯化合物及其合成和应用
ES2827125A1 (es) * 2019-11-19 2021-05-19 Moehs Iberica Sl Intermedio util en la preparacion de remimazolam, su procedimiento de obtencion, y su uso en la obtencion de remimazolam
KR102526590B1 (ko) * 2020-06-19 2023-04-28 하나제약 주식회사 3-[(4S)-8-브로모-1-메틸-6-(2-피리디닐)-4H-이미다조[1,2-a][1,4]벤조디아제핀-4-일]프로피온산 메틸 에스테르의 제조방법
CN112358483A (zh) * 2020-11-09 2021-02-12 中国药科大学 一类新型苯并二氮*类化合物、其制备方法及其用途
CN112321594B (zh) * 2020-12-07 2022-05-20 扬子江药业集团有限公司 一种苯并二氮杂䓬类药物的制备方法
CN114644612B (zh) * 2020-12-17 2023-04-28 成都苑东生物制药股份有限公司 一种苯二氮杂类神经抑制剂中间体化合物的制备方法
CN113717176B (zh) * 2021-10-09 2022-07-05 上海再启生物技术有限公司 一种制备瑞马唑仑的方法
CN114014839A (zh) * 2021-12-16 2022-02-08 上海再启生物技术有限公司 一种制备瑞马唑仑关键中间体的方法
WO2023194945A1 (en) 2022-04-08 2023-10-12 Fresenius Kabi Oncology Ltd. An improved process for the preparation of remimazolam
CN115385891A (zh) * 2022-09-06 2022-11-25 上海药坦药物研究开发有限公司 一种瑞马唑仑中间体的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440959B1 (en) 1999-04-21 2002-08-27 Hoffman-La Roche Inc. Pyrazolobenzodiazepines
GB9911152D0 (en) 1999-05-14 1999-07-14 Glaxo Group Ltd Short-acting benzodiazepines
US8039460B2 (en) * 2004-10-13 2011-10-18 Merck Sharp & Dohme Corp. CGRP receptor antagonists
ATE466853T1 (de) * 2005-01-18 2010-05-15 Merck Sharp & Dohme Cgrp-rezeptorantagonisten
CN103288834B (zh) 2006-07-10 2015-07-15 Paion英国有限公司 短效苯并二氮杂*盐及其多晶型
GB0613692D0 (en) * 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts
GB0613693D0 (en) 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
MX2009012567A (es) * 2007-05-22 2010-02-17 Chemocentryx Inc 3-(imidazolil)-pirazolo[3,4-b]piridinas.
WO2009145323A1 (ja) 2008-05-30 2009-12-03 日産化学工業株式会社 多環式化合物を用いるアルコールの酸化方法
US20110294843A1 (en) 2008-10-16 2011-12-01 Paion Uk Limited Administration scheme of polar opioid metabolites for post-operative pain management
EP2415761B1 (en) 2009-03-30 2013-11-13 Nippon Paper Industries Co., Ltd. Method for recovery/reuse of n-oxyl compound
EP2305647A1 (en) 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
JP5635275B2 (ja) 2010-01-28 2014-12-03 日清紡ホールディングス株式会社 アルコールの酸化方法
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
PT2852389T (pt) 2012-05-22 2017-12-13 Paion Uk Ltd Composições que compreendem benzodiazepinas de ação rápida
JP6199869B2 (ja) 2012-08-31 2017-09-20 パイオン ユーケー リミティド 催眠鎮静剤の投与方式
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión

Also Published As

Publication number Publication date
US9156842B2 (en) 2015-10-13
US20170044135A1 (en) 2017-02-16
MX341093B (es) 2016-08-08
CA2774018A1 (en) 2011-03-24
BR112012006053A2 (pt) 2020-11-03
AU2010294873A1 (en) 2012-04-12
HK1173437A1 (zh) 2013-05-16
CN102753525B (zh) 2015-09-02
HUE028298T2 (en) 2016-12-28
KR20120102603A (ko) 2012-09-18
JP5801309B2 (ja) 2015-10-28
RU2012115456A (ru) 2013-11-10
EP2477967B1 (en) 2015-11-11
MX337683B (es) 2016-03-15
KR101801735B1 (ko) 2017-11-27
EP2305647A1 (en) 2011-04-06
CN102753525A (zh) 2012-10-24
US20150368199A1 (en) 2015-12-24
US9512078B2 (en) 2016-12-06
JP2013505207A (ja) 2013-02-14
RU2551848C2 (ru) 2015-05-27
US20120330007A1 (en) 2012-12-27
EP2477967A1 (en) 2012-07-25
DK2477967T3 (en) 2015-12-21
HRP20151316T1 (hr) 2016-01-15
WO2011032692A1 (en) 2011-03-24
BR112012006053B1 (pt) 2021-11-16
AU2010294873B2 (en) 2014-11-13
PT2477967E (pt) 2016-01-07
CA2774018C (en) 2018-01-30
ES2555233T3 (es) 2015-12-29
PL2477967T3 (pl) 2016-04-29
US10000464B2 (en) 2018-06-19

Similar Documents

Publication Publication Date Title
MX337683B (es) Proceso para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil -6-(2-piridinil) -4h-imidazo [1, 2-a] [1, 4] benzodiacepina-4-il] -propionico o la sal de sulfonato de benceno del mismo, y compuestos utiles en ese proceso.
NZ603268A (en) Process for synthesizing oxidized lactam compounds
SI2900669T1 (sl) Derivati heksahidropirolo(3,4-C)pirola in sorodne spojine kot zaviralci avtotaksina (ATX) in kot zaviralci tvorbe lizofosfatidne kisline (LPA) za zdravljenje npr. bolezni ledvic
MY162022A (en) Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
MY150542A (en) Cmet inhibitors
WO2009140624A3 (en) Glucokinase activators
TN2009000509A1 (en) Pyrazole carboxylic acid amides useful as microbiocides
MX2010009654A (es) Derivados de acido carboxilico de conformacion restringida utiles para tratar trastornos metabolicos.
WO2010008847A3 (en) Pi3k/m tor inhibitors
SI2364308T1 (sl) Pirazinske spojine kot inhibitorji fosfodiesteraze 10
WO2008033836A3 (en) Process and intermediates for preparing integrase inhibitors
WO2010022936A3 (de) Verfahren zur herstellung eines gemisches umfassend mindestens einen anorganischen feststoff und mindestens ein fettsäuresalz, entsprechend hergestellte gemische und deren verwendung
ES2709298A1 (es) Procedimiento para preparar metil ester de acido 3-[(4s)-8-bromo-1-metil-6-(piridin-2-il)-4h-imidazo[1,2-a][1,4]benzodiazepin-4-il]-propionico, y compuestos utiles en ese procedimiento
WO2012034680A3 (de) Phosphorhaltige mischungen, verfahren zu deren herstellung und ihre verwendung
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
EP2193134A4 (en) METHOD FOR THE ORGANOCATALYTIC ACTIVATION OF CARBOXYLIC ACIDS FOR CHEMICAL REACTIONS INVOLVING ORTHO-SUBSTITUTED ARYLBORONIC ACIDS
MX353203B (es) Metodo para producir un derivado heterociclico fenilo sustituido por medio del metodo de acoplamiento utilizando un compuesto paladio.
MX2010013758A (es) Procedimiento para elaborar 2-amino-tiazolonas sustituidas.
MX350430B (es) Proceso para preparar compuestos acido 4-amino-5-bifenil-4-il-2-hi droximetil-2-metil-pentanoico.
TN2014000329A1 (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive
IL185884A0 (en) Method for preparing substittuted pyrimidines
MX2012003616A (es) Proceso para preparar compuestos bifenil imidazol.
WO2009018502A3 (en) Process for the synthesis of diaminopyridine and related compounds

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration